StockData
FRNMNasdaqServices-Medical LaboratoriesFiscal year ends December 31

Freenome, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 15, 2026
$12.57+0.82 (+6.98%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
–

Freenome statistics

Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Services-Medical Laboratories companies for comparison

Valuation

MeasureFreenomeIndustry median
Market Cap$129.64M$1.07B
Enterprise Value$129.20M$1.35B

Income (trailing twelve months)

MeasureFreenomeIndustry median
Operating Income-$4.33M-$1.92M
Net Income-$762.63K-$1.32M
EBITDA-$4.33M-$29.24K

Returns

MeasureFreenomeIndustry median
Return on Assets (ROA)-0.86%-3.06%
Return on Capital Employed (ROCE)-5.27%-2.29%

Balance sheet

MeasureFreenomeIndustry median
Cash & Short-Term Investments$437.37K$47.58M
Net Cash (Debt)$437.37K$217.65K
Net Cash Per Share$0.04$0.01
Equity (Book Value)-$6.30M$189.59M
Book Value Per Share-$0.61$3.32
Tangible Book Value-$6.30M$1.72M
Working Capital-$2.89M$29.77M

Financial position

MeasureFreenomeIndustry median
Current Ratio0.201.41
Quick Ratio0.120.97

Cash flow (trailing twelve months)

MeasureFreenomeIndustry median
Operating Cash Flow-$907.04K$1.28M

Efficiency

MeasureFreenomeIndustry median
Profits Per Employee-$40.14K-$5.96K
Employee Count19897

Dividends and yields

MeasureFreenomeIndustry median
Earnings Yield-0.59%-1.25%

Shares

MeasureFreenomeIndustry median
Shares Outstanding10,313,50058,609,450

Scores

MeasureFreenomeIndustry median
Altman Z-Score10.681.98

Calculated by StockData from Freenome's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.